"The Main Line Center for Laser Surgery is among the world’s leading centers for skin laser surgery and injectables. Led by world-renowned scientist, researcher & dermatologist Dr. Eric Bernstein, and Dr. Kachiu Lee a nationally renowned, Ivy-league trained dermatologist and expert on injectable and laser treatment for medical and cosmetic applications."

During the past decade, Main Line Center for Laser Surgery conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Main Line Center for Laser Surgery" #1 sponsor was "Syneron Medical" with 2 trials, followed by "Zeltiq Aesthetics" with 2 trials sponsored, "Cutera Inc." with 1 trials sponsored, "Eric Bernstein, MD" with 1 trials sponsored and "Kythera Biopharmaceuticals" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Main Line Center for Laser Surgery" #1 collaborator was "Merz North America, Inc." with 1 trials as a collaborator and "Novoxel Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Main Line Center for Laser Surgery" are "Body Fat Disorder" (2 trials), "Photoaging" (1 trials), "Spider Veins" (1 trials), "Submental Fullness" (1 trials) and "Tattoo; Pigmentation" (1 trials). Many other conditions were trialed in "Main Line Center for Laser Surgery" in a lesser frequency.

Most popular intervention types in "Main Line Center for Laser Surgery" are "Device" (7 trials), "Drug" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "532 nm KTP Excel V Laser, manufactured by Cutera, Inc." (1 trials), "Deoxycholic acid" (1 trials), "Energy Devices" (1 trials), "Laser Liposuction" (1 trials) and "Other Treatments" (1 trials). Other intervention names were less common.

The vast majority of trials in "Main Line Center for Laser Surgery" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Main Line Center for Laser Surgery". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Main Line Center for Laser Surgery, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Main Line Center for Laser Surgery, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".